Bulk Pharmaceutical API Sources for SINCALIDE

Bulk Pharmaceutical API Sources for SINCALIDE

Vendor	Vendor Homepage	Vendor Sku	API Url
Molport		MolPort-006-124-517
Amadis Chemical		A817659
Key Organics/BIONET		HS-2026
AKos Consulting & Solutions		AKOS016340423
BOC Sciences		25126-32-3
Glentham Life Sciences Ltd.		GL1683

Bulk Active Pharmaceutical Ingredient (API) Sources for: Sincalide

Last updated: July 30, 2025

Introduction

Sincalide, a synthetic cholecystokinin analog, plays a crucial role in diagnostic imaging, particularly in hepatobiliary and pancreatic assessments. Its pharmaceutical applications rely heavily on high-quality bulk APIs sourced from reputable manufacturers. The global landscape of Sincalide suppliers encompasses diverse regions, with vendors adhering to stringent regulatory standards to ensure safety, efficacy, and consistency. This article analyzes the primary sources of bulk Sincalide API, exploring supplier profiles, manufacturing practices, and market dynamics shaping supply chains in this niche yet vital pharmaceutical segment.

---

Regulatory Standards and Quality Assurance

The procurement of Sincalide API demands strict compliance with international Good Manufacturing Practices (GMP) and regulatory authorities’ requirements, primarily those of the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and other competent agencies. Suppliers must demonstrate robust quality management systems, validated manufacturing processes, and comprehensive analytical testing to ensure purity and stability. Additionally, suppliers often submit Certificates of Analysis (CoA) and rigorous batch documentation, aligning with current pharmacopoeial standards such as USP, EP, or JP.

---

Major Global Sources of Sincalide API

United States and Canada

Leading pharmaceutical companies and Contract Manufacturing Organizations (CMOs) in North America dominate the Sincalide API market. These vendors typically operate under stringent regulatory compliance, leveraging advanced peptide synthesis technology. Notable suppliers include:

• Bachem AG (USA/North America operations): Bachem is a prominent biotech enterprise providing custom peptide synthesis services, including high-purity APIs aligned with FDA standards. Their facilities employ state-of-the-art solid-phase peptide synthesis (SPPS) techniques, ensuring batch-to-batch consistency.

• Peptide International (Kentucky, USA): Specializing in peptide manufacturing, they supply research-grade and GMP-grade peptides, including Sincalide, supporting diagnostic and research applications.

• CS Bio Co., Ltd. (California, USA): Known for peptide synthesis and API manufacturing, adhering to high GMP standards, with a focus on clinical and diagnostic APIs.

Europe

Europe’s API manufacturers benefit from advanced regulatory oversight and technological innovation:

• Bachem AG (Switzerland): As a major global player, Bachem’s European operations extend their high-quality peptide manufacturing capabilities, with a focus on GMP grade Sincalide for clinical and diagnostic uses.

• Peptide Specialty Laboratories (Germany): Offers customized peptide synthesis services for biotech and pharmaceutical clients, with GMP compliance and comprehensive quality control measures.

Asia-Pacific

Asia remains a burgeoning hub for peptide API production, driven by cost advantages and expanding manufacturing capacity:

• Daicel Corporation (Japan): Known for specialty chemical production and peptide synthesis, Daicel maintains high-quality standards, supplying Sincalide to international markets.

• Jiewei Pharmaceutical (China): A large-scale peptide API manufacturer with GMP-certified facilities producing Sincalide for global export, focusing on cost-efficient production without compromising quality.

• Suzhou Peptide Bio-Technology Co., Ltd. (China): Another key supplier offering bulk Sincalide with GMP compliance, catering to both research and diagnostic needs.

Emerging Markets and Contract Manufacturers

Smaller or emerging-market manufacturers are increasingly entering the Sincalide API segment, often via partnerships with established entities. Their capacity varies, but they can provide competitive pricing for research and early-stage clinical applications. These manufacturers, however, require rigorous vetting to affirm adherence to quality standards.

---

Supply Chain Dynamics and Market Trends

The global API supply for Sincalide faces challenges such as geopolitical tensions, supply chain disruptions, and regulatory harmonization efforts. The peptide synthesis industry heavily relies on complex, resource-intensive manufacturing processes requiring specialized expertise and equipment. As demand for diagnostic imaging agents grows, so does the need for reliable API sources.

Recent trends denote a shift toward local manufacturing in key markets, ensuring faster delivery times, reduced regulatory hurdles, and compliance with regional standards. Additionally, advancements in synthetic peptide technology and process optimization have made GMP-grade Sincalide more accessible without compromising safety and purity.

---

Quality and Certification Considerations

Choosing a supplier involves evaluating quality certifications:

• GMP Certification: Indicates compliance with manufacturing standards suitable for clinical and diagnostic uses.
• ISO Certifications: Such as ISO 9001, affirm quality management systems.
• Pharmacopoeial compliance: Ensures API meets monograph standards (USP, EP, JP).

Procurement professionals should also scrutinize stability data, impurity profiles, and manufacturing batch records.

---

Key Supplier Profiles Summary

Supplier	Location	Certification & Standards	Production Focus	Notes
Bachem AG	Switzerland/USA	GMP, FDA, EP, USP	Peptides, APIs	Global leader with extensive peptide synthesis expertise
Peptide International	USA	GMP, USP, EP	Custom peptides	Focus on research and diagnostic-grade peptides
CS Bio Inc.	USA	GMP	Peptide APIs	Advanced synthesis machinery for high purity APIs
Daicel Corporation	Japan	GMP, ISO	Chemical synthesis	Strong Asian manufacturing presence
Jiewei Pharmaceutical	China	GMP, ISO	Peptide APIs	Competitive pricing with expanding export reach
Suzhou Peptide Bio-Tech	China	GMP	Peptide APIs	Emerging supplier, focused on quality assurance

---

Closing Remarks

The global supply of Sincalide API is characterized by a diverse manufacturer base spanning North America, Europe, and Asia, driven by strict adherence to regulatory standards and technological advancements. Established suppliers such as Bachem AG and Daicel maintain high-quality standards crucial for diagnostic applications. Emerging manufacturers, with appropriate due diligence, may offer cost-effective alternatives for research and early-phase clinical development.

---

Key Takeaways

• Regulatory Compliance Is Paramount: Suppliers must possess GMP certification, aligning with international standards, to guarantee API safety and efficacy.
• Global Diversification Enhances Supply Security: Sourcing from multiple regions reduces dependency risks associated with geopolitical or logistical disruptions.
• Technology and Quality Assurance Are Critical: Suppliers employing advanced peptide synthesis and stringent testing protocols ensure high-purity, stable APIs.
• Market Trends Favor Local Manufacturing: Regional production capacities are expanding to meet increasing demand and streamline supply chains.
• Due Diligence Is Essential: Establish clear qualification procedures, including review of Certificates of Analysis and quality certifications, before engagement.

---

FAQs

1. What are the primary regions producing bulk Sincalide API?
   North America, Europe, and Asia-Pacific are the principal regions, with established manufacturers in the U.S., Switzerland, Germany, Japan, and China.

2. What quality certifications should I look for in a Sincalide API supplier?
   Suppliers should have GMP certification, ISO 9001, and demonstrate compliance with pharmacopoeial standards (USP, EP, JP).

3. Are emerging market suppliers reliable for diagnosis-grade Sincalide?
   They can be, provided they demonstrate consistent quality records, GMP compliance, and transparent analytical data. Due diligence is vital.

4. How does technological innovation influence API quality?
   Advanced peptide synthesis technologies improve purity, yield, and batch consistency, reducing impurities and enhancing safety.

5. What factors should influence sourcing decisions for Sincalide API?
   Key factors include regulatory compliance, quality assurance, production capacity, lead time, cost, and supplier track record.

---

References

1. Bachem AG. (2022). Quality Standards and Manufacturing Processes.
2. Peptide International. (2022). Product Quality and Certification.
3. Daicel Corporation. (2022). Peptide and Synthetic APIs.
4. European Medicines Agency. (2022). Guidelines on Good Manufacturing Practices.
5. U.S. Food and Drug Administration. (2022). Regulatory Requirements for Peptide APIs.